The Center for Biotechnology & Interdisciplinary Studies at Rensselaer

The Center for Biotechnology & Interdisciplinary Studies (CBIS) is uniquely focused on fostering collaborative research across disciplines. Researchers from life sciences, physical science, informatics, bioengineering, data modeling, bioimaging, engineering, lighting systems and engineering, and media technologies can come together to work on global challenges.

As the hub of biotechnology-based research at Rensselaer Polytechnic Institute, the Center is recognized for its basic and applied research, world-class infrastructure and support staff, and growing funding base.

Our research portfolio includes ground-breaking work in biologics, bioimaging, biomanufacturing, biomolecular science and engineering, biophysics and structural biology, microbiomics, neuroscience, stem cell engineering, and genomics.  More about CBIS

Over Ten Years

  • 36 Faculty
  • 200 Ph.D.s Granted
  • 1,000 Undergrads Trained
  • 2,000 Peer-Reviewed Publications
  • 30,000 Citations (ISI)
  • $130MExternal Grant Funding

News & Events

Hepatitis C Drugs Multiply Effect of COVID-19 Antiviral Remdesivir

When combined with drugs currently used to treat hepatitis C, the antiviral remdesivir is 10 times more effective in treating cells infected with SARS-CoV-2, the virus that causes COVID-19.

Self-Built Protein Coatings Could Improve Biomedical Devices

Fouling is a natural phenomenon that describes the tendency of proteins in water to adhere to nearby surfaces. It’s what causes unwanted deposits of protein to form during some food production or on biomedical implants, causing them to fail. Researchers at Rensselaer Polytechnic Institute are harnessing this process, which is typically considered a persistent challenge, to develop a versatile and accessible approach for modifying solid surfaces.

Polymerized Estrogen Provides Neuroprotection in Preclinical Testing

A novel form of polymerized estrogen developed at Rensselaer Polytechnic Institute can provide neuroprotection when implanted at the site of a spinal cord injury — preventing further damage. This promising result, found in a preclinical model, was recently published in ACS Chemical Neuroscience, and it lays the groundwork for further advancement of this new biomaterial.  

Time Needed To Sequence Key Molecules Could Be Reduced From Years to Minutes

Using a nanopore, researchers have demonstrated the potential to reduce the time required for sequencing a glycosaminoglycan — a class of long chain-linked sugar molecules as important to our biology as DNA — from years to minutes.

Our Center

  • 150 PhD Students
  • 50 Postdoctoral Fellows
  • 33 Principal Investigator Laboratories
  • 25 Visiting Research Scientists
  • 218,000 sq ft modern facility
  • 31, 240 sq ft of open research labs
  • 13,009 sq ft of support labs
  • 27,350 sq ft of core facilities
  • 5,830 sq ft conference and seminar space